By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanofi Pasteur 

174, av. de France

Paris    75013  France
Phone: 33-1-53-77-4076 Fax: 33-1-53-77-4174



Company News
Terrapinn Release: Experts From Merck & Co. (MRK), GlaxoSmithKline (GSK), Pfizer (PFE), Sanofi Pasteur (SASY.PA) And More To Debate Breakthroughs For Vaccines For Ebola, Zika And Cancer. 3/7/2016 10:20:07 AM
Sanofi Pasteur (SASY.PA) Release: High-Dose Influenza Vaccine Recognized As A New Option With Demonstrated Superior Efficacy* For Adults 65 Years And Older 2/24/2016 9:24:26 AM
The Human Vaccines Project Welcomes Sanofi Pasteur (SASY.PA) To Its Global Consortium 1/15/2016 1:22:28 PM
Sanofi Pasteur (SASY.PA)'s Dengue Vaccine Approved in the Philippines 12/22/2015 7:36:16 AM
Sanofi Pasteur (SASY.PA) to Launch World's First Dengue Vaccine in Mexico 12/10/2015 5:31:32 AM
Sanofi Pasteur (SASY.PA) Proposes Expansion that Will Create 100 New Jobs in Pennsylvania 11/16/2015 6:56:08 AM
Infectious Disease Research Institute (IDRI) And Sanofi Pasteur (SASY.PA) Team With Philanthropy To Develop New Model For Vaccine Development 10/15/2015 9:52:49 AM
Dyadic International, Inc. Receives C1 Derived Vaccine Test Results From Sanofi Pasteur (SASY.PA) And Provides Further Details On New EU-Funded ZAPI Biopharmaceutical Program 10/7/2015 11:45:21 AM
Sanofi Pasteur (SASY.PA) Release: New Analysis Reports Lower Rates Of Serious Cardio-Respiratory Events Among Study Participants Administered Higher-Dose Influenza Vaccine 8/3/2015 6:33:17 AM
Sanofi Pasteur (SASY.PA) Ships First 2015-2016 Seasonal Influenza Vaccine Doses In United States 7/14/2015 6:49:37 AM